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Abstract
Background: The aim of this study was to understand whether acupuncture can decrease the risk of coronary
heart disease (CHD) in patients with fibromyalgia.
Methods: Using data from the Taiwanese National Health Insurance Research Database, we performed a propensity
score-matched cohort study to analyze patients with fibromyalgia diagnosed between 1 January 2000 and 31
December 2010. Patients who received acupuncture treatment, beginning with their initial date of fibromyalgia
diagnosis and extending to 31 December 2010, were regarded as the acupuncture cohort. The no-acupuncture
cohort comprised patients who never received acupuncture through 31 December 2010. A Cox regression model
was used to adjust for age, sex, comorbidities, and drugs used. The HRs of the acupuncture and no-acupuncture
cohorts were compared.
Results: After performing a 1:1 propensity score match, 58,899 patients in both cohorts were identified. Baseline
characteristics were similar in both cohorts. The cumulative incidence of CHD was significantly lower in the
acupuncture cohort (log-rank test, p < 0.001). In the follow-up period, 4389 patients in the acupuncture cohort (17.
44 per 1000 person-years) and 8133 patients in the no-acupuncture cohort (38.36 per 1000 person-years) developed
CHD (adjusted HR 0.43, 95% CI 0.41–0.45). The beneficial effect of acupuncture on the incidence of CHD was
independent of age, sex, comorbidities, and statins used.
Conclusions: Our study confirmed that acupuncture reduced the risk of CHD in patients with fibromyalgia in
Taiwan. Further clinical and mechanistic studies are warranted.
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Background
Fibromyalgia, characterized by chronic widespread pain,
commonly presents with associated symptoms such as
fatigue, sleep disturbance, depression, cognitive dysfunc-
tion, and headache [1, 2]. The American College of
Rheumatology published the criteria for fibromyalgia,
which were modified in 2010 [3]. The global mean
prevalence of fibromyalgia in the general population was
2.7%, and the female-to-male ratio was 3:1 [4]. The qual-
ity of life (QOL) of patients with fibromyalgia is always
impaired, and about one-third of patients have difficul-
ties in performing the activities of daily living. The high
incidence of comorbidities is another health care prob-
lem. Researchers in previous studies reported that pa-
tients with fibromyalgia in the United States were two to
seven times more likely to have comorbidities [5]. Ac-
cording to the U.S. National Health Interview Survey,
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myocardial infarction occurred more than twice as often
in patients with fibromyalgia as in patients without
fibromyalgia [6]. In Korea, chronic emotional stress in
postmenopausal women with fibromyalgia impaired
myocardial function [7]. In Taiwan, a population-based
cohort study revealed that the risk of coronary heart dis-
ease (CHD) in patients with fibromyalgia was 47%
higher than in the general population [8].
Current treatment strategies for fibromyalgia include
pharmacological and nonpharmacological methods. Preg-
abalin, duloxetine, and milnacipran are U.S. Food and
Drug Administration (FDA)-approved drugs for treating
patients with fibromyalgia, but the efficacy of these drugs
has been questioned because of the small sample sizes in
clinical trials [9]. Nonpharmacological treatments of fibro-
myalgia include acupuncture, massage, and exercise. Be-
cause the pathological mechanisms of fibromyalgia are
not yet fully understood, current treatments are focused
on attenuating symptoms and improving QOL.
Animal studies and clinical trials revealed that acupunc-
ture has a beneficial effect in the treatment of fibromyalgia
[10, 11]. However, there is no long-term follow-up study
showing whether acupuncture can decrease the risk of
CHD in patients with fibromyalgia. The Taiwanese Na-
tional Health Insurance Research Database (NHIRD) pro-
vides information on the entire population of Taiwan with
long-term follow-up data for interventions. The advantage
of using this database is that it prevents sampling bias
[12]. The National Health Insurance (NHI) program was
implemented in 1995 in Taiwan by the National Health
Insurance Administration (NHIA). Traditional Chinese
medicine (TCM) services have been reimbursed through
the NHI program since 1996 [13]. The use of TCM
services, including herbal medicine and acupuncture,
is common in Taiwan for the treatment of many
kinds of disease [14–17]. To understand whether acu-
puncture can decrease the risk of CHD in patients
with fibromyalgia, we investigated a randomly selected
sample of 1 million people enrolled in the NHIRD
from 2000 to 2010.
Methods
Data sources
We conducted a nationwide, population-based, 1:1 pro-
pensity score-matched cohort study by analyzing data
derived from the NHIRD. The data source of our study
was the Longitudinal Health Insurance Database 2000,
which contains all the original claims data of 1 million
beneficiaries randomly sampled from the registry of all
beneficiaries in 2000. The sampled patients exhibited no
significant difference in age, sex, birth year, or average
insured payroll-related costs from the general popula-
tion. The International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM), codes were
used for diagnoses. Because the NHIRD contains identi-
fied secondary data for research, the present study
was waived from the need for informed consent. This
study was approved by the research ethics committee
of China Medical University and Hospital
(CMUH104-REC2-115).
Study cohort identification
Patients newly diagnosed with fibromyalgia from 1 Janu-
ary 2000 to 31 December 2010 were identified (Fig. 1).
To be included, patients with fibromyalgia should have
had at least two ambulatory or inpatient claims with the
diagnosis of ICD-9-CM codes 729.0 and 729.1. The ex-
clusion criteria included age younger than 18 years, in-
complete information on age and sex, and withdrawal
from the NHIRD during the follow-up period. Patients
who received acupuncture from their initial diagnosis of
fibromyalgia to 31 December 2010 were identified as the
acupuncture cohort. Propensity score approaches were
used to reduce confounding by the indication of acu-
puncture treatment. We used a 1:1 propensity score
match by sex, age (per 5 years), comorbidities, drugs
used, and the year in which fibromyalgia was diag-
nosed through multiple logistic regression analysis.
Ultimately, equal numbers of patients in the acupunc-
ture and no-acupuncture cohorts were analyzed in
this study. The immortal time of acupuncture cohort
was the period between the first time of receiving
acupuncture and the date of initial diagnosis with
fibromyalgia. The claims data for both cohorts were
assessed from the initial diagnosis date to 31 Decem-
ber 2011 (the end of this study).
Covariate assessment
Sociodemographic factors included age and sex. Patients
were divided into three groups according to their age
(18–39 years, 40–59 years, and older than 60 years).
Baseline comorbidities were considered present if ICD-
9-CM codes appeared two or more times in outpatient
or inpatient claims before the initial diagnosis of fibro-
myalgia, which included diabetes mellitus (DM; ICD-9-
CM code 250), hypertension (ICD-9-CM codes 401–
405), hyperlipidemia (ICD-9-CM code 272), congestive
heart failure (ICD-9-CM codes 402.01, 402.11, 402.91,
404.01, 404.03, 404.11, 404.13, 404.91, 404.93, and
428.0), stroke (ICD-9-CM codes 430–438), depression
(ICD-9-CM codes 296.2–296.3, 300.4, and 311), anxiety
(ICD-9-CM codes 300.0, 300.2, 300.3, 308.3, and
308.91), alcoholism or alcohol-related disorders (ICD-9-
CM codes 291, 303, 305.00–305.03, 790.3, and V11.3),
tobacco dependence (ICD-9-CM code 305.1), and obes-
ity (ICD-9-CM codes 278 and A183).
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Types of acupuncture and disease categories in the
acupuncture cohort
We analyzed the acupuncture type that patients received
by the treatment codes, which included manual acu-
puncture of TCM type (B41, B42, B45, B46, B80-B84,
B90–B94, P27041, P31103, P32103, and P33031) and
electroacupuncture (B43, B44, B86–B89, and P33032).
Disease categories for which patients with fibromyalgia
received acupuncture were identified by the ICD-9-CM
codes. More than one ICD-9-CM code may be recorded
when patients receive acupuncture, so the total numbers
of patients in all categories were more than the number
of patients in the acupuncture cohort.
Statistical analyses
We compared the baseline characteristics of the acu-
puncture and no-acupuncture cohorts using standard-
ized mean differences. Standardized mean differences
with less than 0.1 SD indicated a negligible difference in
mean values or proportions between the two cohorts.
The HR and 95% CI were calculated for each variable by
Cox proportional hazards regression. The difference be-
tween the two cohorts in the development of CHD was
estimated using the Kaplan-Meier method and the log-
rank test.
Statistical analysis was performed and figures were
created using SAS 9.4 (SAS Institute, Cary, NC, USA)
and R software (R Foundation for Statistical Computing,
Vienna, Austria). p < 0.05 in two-tailed tests indicated
statistical significance.
Results
Using the NHIRD, we identified 189,512 patients with
fibromyalgia newly diagnosed between 1 January 2000
and 31 December 2010 (Fig. 1). After excluding pa-
tients with missing information or lacking follow-up,
158,425 patients were included. Among included
patients, 81,843 received acupuncture and 76,582
patients never received acupuncture from the initial
fibromyalgia diagnosis date to 31 December 2010. To
minimize the differences in basic data between these
two cohorts, we used a 1:1 propensity score match to
randomly select 58,899 patients each for the acupunc-
ture and no-acupuncture cohorts.
The baseline characteristics of both cohorts are
shown in Table 1, and they were similar in sex, age,
comorbidities, and drugs used. The proportion of
women was higher than men in both cohorts, and
the dominant age group was 40–59 years. The most
common comorbidity was hypertension, which was
present in more than 20% of patients. Among the pa-
tients with fibromyalgia, 17% had hyperlipidemia, 11%
had anxiety, 10.6% had DM, 6.9% had stroke, 4.9%
had depression, and 1% had congestive heart failure.
Fig. 1 Study population flowchart. After the exclusion process, we identified 158,425 patients with fibromyalgia newly diagnosed between 2000 and 2010.
After matching 1:1 by sex, age, comorbidities, and drugs used, the acupuncture cohort and no-acupuncture cohorts each contained 58,899 patients. LHID
2000 Longitudinal Health Insurance Database 2000, NHI National Health Insurance
Wu et al. Arthritis Research & Therapy  (2017) 19:37 Page 3 of 10
The proportions of patients diagnosed with alcohol-
ism or alcohol-related disorders, tobacco dependence,
and obesity were similar in both cohorts. Almost all
patients in both cohorts used nonsteroidal anti-
inflammatory drugs (NSAIDs), and approximately 67%
of patients used oral steroids. About 13.5% of patients
took statins for hyperlipidemia in the no-acupuncture
and acupuncture cohorts. The mean duration between
the initial diagnosis of fibromyalgia and the first time
receiving acupuncture was approximately 919 days.
The average number of acupuncture visits was 7.45.
Most patients (85%) received manual acupuncture of
TCM type, and 3.6% patients received electroacu-
puncture. About 10.7% of patients received both types
of treatment.
During the follow-up period, there were 12,522 patients
included in our study who developed CHD (Table 2). The
incidence of CHD in patients with fibromyalgia increased
depending on age (adjusted HRs 4.24 and 6.24 in 40–59
years and ≥60 years age groups, respectively). Patients
with fibromyalgia with comorbidities also developed CHD
more easily than patients without comorbidities. Overall,
the incidence of CHD was significantly lower in the acu-
puncture cohort than in the no-acupuncture cohort (ad-
justed HR 0.43, 95% CI 0.41–0.45).
Figure 2 reveals that the cumulative incidence of CHD
was significantly lower in the acupuncture cohort during
the follow-up period (log-rank test, p < 0.001). In this
study, 4389 patients in the acupuncture cohort (17.44
per 1000 person-years) and 8133 patients in the no-
acupuncture cohort (38.36 per 1000 person-years) devel-
oped CHD (adjusted HR 0.43, 95% CI 0.41–0.45)
(Table 3). The beneficial effect of acupuncture on the in-
cidence of CHD was observed in both female and male
patients (adjusted HR 0.48 in women, 95% CI 0.46–0.51;
adjusted HR 0.47 in men, 95% CI 0.45–0.50). Although
the risk of CHD gradually increased with age, acupunc-
ture significantly decreased the incidence of CHD in all
age groups. Acupuncture decreased the risk of CHD in
patients with fibromyalgia with or without comorbidities.
Regardless of whether patients took oral steroids, NSAIDs,
or statins, fewer patients in the acupuncture cohort devel-
oped CHD than in the no-acupuncture cohort.
Table 4 reveals the top ten disease categories for which
the patients with fibromyalgia in the acupuncture cohort
received acupuncture treatment. The most common
conditions leading to visiting acupuncture doctors were
disorders of the musculoskeletal system and connective
tissues that are highly related to fibromyalgia. Injury was
also a common reason for receiving acupuncture.
Discussion
To our knowledge, our present nationwide population-
based study is the first to reveal that acupuncture









n % n %
Sex
Female 33,331 56.59 33,447 56.79 0.004
Male 25,568 43.41 25,452 43.21
Age group, years
18–39 24,487 41.57 23,572 40.02 0.032
40–59 27,481 46.66 29,748 50.51 0.077
≥60 6931 11.77 5579 9.47 0.075
Mean (±SD), years 44.57 (15.43) 44.28 (14.44) 0.02
Baseline comorbidities
Diabetes mellitus 6252 10.61 6098 10.35 0.009
Hypertension 12,457 21.15 12,036 20.43 0.018
Hyperlipidemia 10,097 17.14 10,034 17.04 0.003
Congestive heart
failure
569 0.97 508 0.86 0.011
Cerebrovascular
diseases
4044 6.87 3786 6.43 0.018
Depression 2863 4.86 2840 4.82 0.002




311 0.53 316 0.54 0.001
Tobacco dependence 289 0.49 270 0.46 0.005
Obesity 439 0.75 427 0.72 0.002
Drugs used
Oral steroids 39466 67.01 39495 67.06 0.001
NSAIDs 57613 97.82 57734 98.02 0.014




– – 50,470 85.69
















3.60 (3.02) 4.27 (3.79)
NSAIDs Nonsteroidal anti-inflammatory drugs, TCM Traditional
Chinese medicine
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decreases the risk of CHD in patients with fibromyalgia.
As a popular treatment for fibromyalgia, acupuncture
has been performed on patients with fibromyalgia in
several clinical trials. However, the outcome evaluation
was previously always focused on pain score, sleep qual-
ity, and QOL [10]. In our study, we found that the bene-
ficial effects of acupuncture on developing CHD in
patients with fibromyalgia were independent of sex, age,
comorbidities, and anti-inflammatory drugs included in
our data. Statins, the inhibitors of the 3-hydroxy-3-
methylglutaryl-coenzyme A reductase for treating hyper-
lipidemia, were previously reported to reduce the risk of
cardiovascular diseases [18]. Our study revealed that re-
gardless of whether patients with fibromyalgia took sta-
tins, acupuncture lowered the risk of CHD.
Our study revealed that more than half of patients
with fibromyalgia in Taiwan have received acupuncture.
A previous report revealed that the leading reason for
patients in Taiwan to seek acupuncture treatment was
diseases of the musculoskeletal system and connective
tissue [19]. Fibromyalgia also belongs to this disease cat-
egory. This is true not only in Taiwan, because patients
with fibromyalgia also receive acupuncture in the other
countries, such as Germany [20]. Previous studies in the
United States, Spain, and Iran have demonstrated the ef-
ficacy of acupuncture in fibromyalgia [21–23].
A strength of our study is the comprehensive, large-
scale database that we used, Taiwan’s NHIRD. This data-
base provides an enormous sample size to reduce selec-
tion and participation bias, and it includes long-term
follow-up data [12]. In addition, the characteristics of
patients with fibromyalgia in our study were consistent
with those in previous reports of female and middle-
aged predominance in other countries [6, 24]. These
baseline characteristics were similar in both cohorts in
our study.
Table 2 Hazard ratios of coronary heart disease associated with acupuncture and covariates among patients with fibromyalgia
Variable Number of events (n = 12,522) Crude HR (95% CI) p Value Adjusted HR (95% CI) p Value
Received acupuncture
No 8133 1.00 Reference 1.00 Reference
Yes 4389 0.48 (0.46–0.5) <0.0001 0.43 (0.41–0.45) <0.0001
Sex
Female 7138 1.00 Reference 1.00 Reference
Male 5384 0.98 (0.95–1.02) 0.3907 1.03 (0.99–1.07) 0.1072
Age group, years
18–39 1248 1.00 Reference 1.00 Reference
40–59 7946 5.24 (4.94–5.56) <0.0001 4.24 (3.99–4.51) <0.0001
≥60 3328 11.33 (10.62–12.1) <0.0001 6.24 (5.81–6.71) <0.0001
Baseline comorbidities (reference = nonsite comorbidity)
Diabetes mellitus 2994 2.9 (2.78–3.02) <0.0001 1.37 (1.31–1.44) <0.0001
Hypertension 6188 4.03 (3.89–4.18) <0.0001 2.20 (2.11–2.3) <0.0001
Hyperlipidemia 4452 2.88 (2.78–2.99) <0.0001 1.63 (1.56–1.7) <0.0001
Congestive heart failure 298 3.19 (2.85–3.58) <0.0001 1.17 (1.04–1.32) 0.0078
Cerebrovascular diseases 1966 2.81 (2.68–2.95) <0.0001 1.25 (1.19–1.32) <0.0001
Depression 803 1.48 (1.38–1.59) <0.0001 1.1 (1.02–1.18) 0.0131
Anxiety 1960 1.61 (1.53–1.69) <0.0001 1.21 (1.15–1.27) <0.0001
Alcoholism or alcohol-related disorders 57 0.97 (0.75–1.25) 0.8031 0.93 (0.72–1.21) 0.5941
Tobacco dependence 39 0.9 (0.66–1.23) 0.5098 0.83 (0.6–1.13) 0.2391
Obesity 109 1.34 (1.11–1.62) 0.0024 1 (0.83–1.21) 0.9629
Drugs used
Oral steroids 7490 0.62 (0.6–0.64) <0.0001 0.54 (0.52–0.56) <0.0001
NSAIDs 11,804 0.21 (0.19–0.23) <0.0001 0.24 (0.22–0.26) <0.0001
Statins 2218 1.28 (1.22–1.34) <0.0001 0.55 (0.52–0.58) <0.0001
NSAIDs Nonsteroidal anti-inflammatory drugs
a Crude HR represents relative hazard ratio
b Adjusted HR represents adjusted hazard ratio mutually adjusted for accepted acupuncture, age, sex, diabetes mellitus, hypertension, hyperlipidemia, congestive
heart failure, cerebrovascular diseases, depression, anxiety, alcoholism or alcohol-related disorders, tobacco dependence, obesity, oral steroids, NSAIDs, and statins
in Cox proportional hazards regression
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In Taiwan, the majority of TCM doctors are graduated
from baccalaureate TCM education programs (7- or 8-
year medical doctor programs) or postbaccalaureate
TCM programs (5-year medical doctor programs) in
universities. The graduated students must pass the board
examination conducted by the government. The training
programs on the manipulation of acupuncture are stan-
dardized. The duration of needle retention most com-
monly performed is about 20–30 minutes in Taiwan,
and achievement of deqi is a basic requirement in acu-
puncture treatment.
Pregabalin was the first FDA-approved drug for treat-
ment of fibromyalgia [1]. It was demonstrated to im-
prove pain, sleep disturbance, and fatigue in adult
patients with fibromyalgia [25]. In our present study, we
did not compare the efficacy of acupuncture with prega-
balin, because this drug was not reimbursed by Taiwan-
ese NHIA for fibromyalgia until 2015. Whether
pregabalin decreases the incidence of CHD in patients
with fibromyalgia has never been reported. Furthermore,
pregabalin has cardiac adverse effects because it may in-
duce heart failure [26]. Acupuncture has been reported
to attenuate both ischemic injury of the heart and heart
failure [27, 28]. Whether acupuncture treatment pro-
vides benefits to those patients receiving pregabalin de-
serves future investigation.
Fibromyalgia is thought to arise from aberrant brain
chemistry, function, and structure [29]. The effects of
acupuncture have also been documented to affect the
central nervous system to ameliorate fibromyalgia [30].
An increasing body of evidence suggests that central
sensitization contributes to hyperalgesia and allodynia in
patients with fibromyalgia. Activation of N-methyl-D-as-
partate receptor (NMDAR) and cyclic adenosine
monophosphate-responsive element binding protein pro-
motes hyperalgesia [29]. In a previous study on fibromyal-
gia, researchers using a murine model found that
activation of the dorsal root ganglion was suppressed by
acupuncture [31]. Activation of cardiac NMDAR induces
oxidative stress and facilitates atrial fibrillation that were
attenuated by NMDAR antagonists [32, 33]. Inhibition of
NMDAR is the possible mechanism to prevent CHD in
fibromyalgia, and whether acupuncture can suppress car-
diac NMDAR in fibromyalgia needs further evaluation.
Other than the NMDAR pathway, the 5-HT3 receptor
may be another target of acupuncture to decrease CHD
in fibromyalgia. The analgesic effect of acupuncture is
also evident through the 5HT3 receptor in a rat model
of collagenase-induced arthritis, and 5-HT3 receptor an-
tagonists have beneficial effects on autonomic cardiac
dysfunction in patients with fibromyalgia [34, 35]. How-
ever, the results of our present study were contrary to
those of a previous study involving transient receptor
potential vanilloid 1 (TRPV1). Overexpression of TRPV1
in the spinal cord was suppressed by acupuncture in a
fibromyalgia murine model [11], but TRPV1 in the
endothelium prevents CHD [36]. The heart-protective
effect of acupuncture in fibromyalgia may not be
through the TRPV1 pathway.
Antidepression, anti-inflammation, and improvement
of sleep quality are also possible mechanisms of acu-
puncture to prevent CHD in fibromyalgia. In previous
reports, acupuncture improved sleep quality in patients
with insomnia, which is highly associated with fibro-
myalgia and CHD [37–39]. Depression is a common as-
sociated symptom of fibromyalgia, and it increases the
incidence of CHD through deregulation of the auto-
nomic nervous system and the hypothalamic-pituitary-
adrenal axis [40]. Acupuncture stabilized this axis, acti-
vated the hippocampal serotonin system, and suppressed
inflammation to attenuate depression [41, 42].
Comorbidities of fibromyalgia, including DM, hyperten-
sion, and heart disease, are highly associated with chronic
inflammation. Many previous studies of acupuncture were
focused on the analgesic effect of acupuncture, but add-
itional studies in recent years demonstrated that acupunc-
ture attenuated inflammation. Acupuncture attenuated
inflammation through the vagus nerve mediated by dopa-
mine [43]. The combination of acupuncture and moxibus-
tion relieved Crohn’s disease by decreasing the ratio of
Th17 to Treg cells in the intestinal mucosa [44]. These
studies support that acupuncture has not only an anal-
gesic effect but also an anti-inflammatory effect.
In addition, researchers in a previous study found that
acupuncture before percutaneous coronary intervention
in patients with acute myocardial infarction attenuated
Fig. 2 Cumulative incidence of coronary heart disease (CHD)
between the acupuncture cohort and the no-acupuncture cohort.
The cumulative incidence of CHD in the acupuncture cohort (dashed
line) is significantly lower than in the no-acupuncture cohort (solid
line) (log-rank test, p < 0.001)
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Table 3 Incidence rates and hazard ratios for coronary heart disease among patients with fibromyalgia with or without acupuncture
treatment
Variable No acupuncture (n = 58,899) Acupuncture (n = 58,899)
Events Person-years IR Events Person-years IR Crude HR (95% CI) Adjusted HRa (95% CI)
Total 8133 212,027 38.36 4389 251,711 17.44 0.48 (0.46–0.50)b 0.43 (0.41–0.45)b
Sex
Female 4650 120,934 38.45 2488 141,235 17.62 0.48 (0.46–0.51)b 0.43 (0.41–0.45)b
Male 3483 91,093 38.24 1901 110,476 17.21 0.47 (0.45–0.5)b 0.45 (0.43–0.48)b
Age group, years
18–39 877 92,941 9.44 371 94,477 3.93 0.42 (0.38–0.48)b 0.39 (0.35–0.44)b
40–59 5059 99,271 50.96 2887 133,190 21.68 0.45 (0.43–0.47)b 0.42 (0.41–0.44)b
≥60 2197 19,814 110.88 1131 24,044 47.04 0.48 (0.45–0.52)b 0.47 (0.43–0.5)b
Baseline comorbidities
Diabetes mellitus
No 6227 193,111 32.25 3301 225,893 14.61 0.47 (0.45–0.5)b 0.44 (0.42–0.46)b
Yes 1906 18,916 100.76 1088 25,818 42.14 0.46 (0.42–0.49)b 0.44 (0.41–0.47)b
Hypertension
No 4148 174,292 23.80 2186 199,801 10.94 0.48 (0.45–0.5)b 0.43 (0.41–0.46)b
Yes 3985 37,735 105.61 2203 51,910 42.44 0.44 (0.42–0.47)b 0.44 (0.42–0.46)b
Hyperlipidemia
No 5328 180,288 29.55 2742 210,271 13.04 0.46 (0.44–0.48)b 0.43 (0.41–0.45)b
Yes 2805 31,738 88.38 1647 41,440 39.74 0.49 (0.46–0.52)b 0.46 (0.43–0.49)b
Congestive heart failure
No 7942 210,670 37.70 4282 249,749 17.15 0.48 (0.46–0.5)b 0.44 (0.42–0.45)b
Yes 191 1356 140.83 107 1963 54.52 0.45 (0.35–0.57)b 0.46 (0.36–0.59)b
Cerebrovascular diseases
No 6867 199,807 34.37 3689 235,364 15.67 0.48 (0.46–0.5)b 0.44 (0.42–0.45)b
Yes 1266 12,220 103.60 700 16,348 42.82 0.46 (0.42–0.5)b 0.45 (0.41–0.49)b
Depression
No 7628 203,237 37.53 4091 240,799 16.99 0.48 (0.46–0.49)b 0.44 (0.42–0.45)b
Yes 505 8790 57.45 298 10,912 27.31 0.51 (0.44–0.59)b 0.46 (0.4–0.53)b
Anxiety
No 6860 191,626 35.80 3702 225,730 16.40 0.48 (0.46–0.5)b 0.44 (0.42–0.46)b
Yes 1273 20,401 62.40 687 25,982 26.44 0.46 (0.42–0.5)b 0.43 (0.39–0.47)b
Alcoholism or alcohol-related disorders
No 8093 211,137 38.33 4372 250,521 17.45 0.48 (0.46–0.5)b 0.44 (0.42–0.46)b
Yes 40 889 44.99 17 1190 14.28 0.35 (0.2–0.61)b 0.33 (0.19–0.6)b
Tobacco dependence
No 8109 211,341 38.37 4374 251,047 17.42 0.48 (0.46–0.5)b 0.44 (0.42–0.45)b
Yes 24 685 35.02 15 664 22.58 0.68 (0.35–1.29) 0.47 (0.23–0.94)c
Obesity
No 8062 210,777 38.25 4351 250,115 17.40 0.48 (0.46–0.5)b 0.44 (0.42–0.46)b
Yes 71 1250 56.80 38 1596 23.81 0.45 (0.3–0.66)b 0.36 (0.24–0.55)b
Drugs used
Oral steroids
No 3458 56,042 61.70 1574 74,258 21.20 0.39 (0.37–0.41)b 0.39 (0.37–0.42)b
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cardiac injury [45]. Acupuncture also decreased myocar-
dial infarct areas and preserved cardiac function through
heat shock protein 20 (HSP20) and HSP27 in an animal
study [27]. These reports demonstrated that acupunc-
ture can protect the heart from ischemia. Future mech-
anistic study in this area is warranted.
Several limitations in our study are noted. First, the
NHIRD did not provide the severity of fibromyalgia, includ-
ing pain scores, the severity of inflammation, or daily life
disabilities. To minimize the confounding factors, we per-
formed a 1:1 propensity score match and found that the
baseline characteristics of both cohorts were similar. The
percentages of patients who used NSAIDs and oral steroids
were also similar in both cohorts. The second limitation is
that the NHIRD did not provide data about patients’ life-
styles, such as smoking, alcohol drinking, body mass index
(BMI), stress, and exercise. Although detailed information
about smoking exposure, alcohol drinking, and BMI was
not available, we were able to acquire information on ill-
nesses resulting from these personal habits and lifestyles.
We conducted a 1:1 propensity score match that included
the diagnoses of alcoholism or alcohol-related disorders, to-
bacco dependence, and obesity. Patients with these disor-
ders were similar in both cohorts, and the protective effect
of acupuncture on CHD was significant in patients with
fibromyalgia with these comorbid diseases. However, there
was still an underestimation of smoking exposure and alco-
hol drinking in both cohorts. On the basis of our findings
in this matched cohort study, we have designed a pro-
spective participant- and assessor-blinded, randomized
controlled trial to investigate the efficacy and mechanisms
of acupuncture in patients with fibromyalgia (Clinical-
Trials.gov identifier: NCT02583334). These lifestyle fac-
tors are recorded using a patient-reported questionnaire
and should be able to provide more information regarding
lifestyle. The third limitation was that detailed information
on selected acupoints was not provided in the dataset.
Acupoint selection was individualized according to the
TCM diagnosis of patients and the experience of doctors,
which is more like an effectiveness study. Most studies on
the efficacy of acupuncture fix the acupoints to
standardize their treatment protocol. The clinical trial of
acupuncture in patients with fibromyalgia we conducted
also fixed the acupoints as LI4, LI11, LR3, ST36, SP6, and
GB34, which are commonly used acupoints for the treat-
ment of patients with fibromyalgia.
Conclusions
Our present study confirms that acupuncture reduced
the risk of CHD in patients with fibromyalgia in Taiwan.
This noteworthy finding can provide some hints for fur-
ther clinical and mechanistic studies.
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